Hypopigmented Skin Lesions After Immunotherapy

JAMA Oncol. 2018 Aug 1;4(8):1118-1119. doi: 10.1001/jamaoncol.2018.0186.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / adverse effects*
  • Female
  • Humans
  • Hypopigmentation / chemically induced*
  • Hypopigmentation / pathology
  • Immunotherapy / adverse effects*
  • Nivolumab / adverse effects*
  • Prognosis
  • Sarcoma, Alveolar Soft Part / drug therapy*
  • Skin Diseases / chemically induced*
  • Skin Diseases / pathology

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab